# Sofinnova MD Start IV: venture capital fund, $7.1 million

Read November 19, 2026 from the Form ADV filings through October 31, 2026.

Sofinnova MD Start IV is a venture capital fund managed by Sofinnova Partners, an adviser in Paris, France. Its adviser reported $7,095,033 in gross assets, 19 beneficial owners and a minimum investment of $100,000 in the Form ADV filed March 27, 2026. It is organized in France.

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (adviser city, adviser state, percent owned by non US persons, auditor, administrator, custodians and 2 more), which open on your screen as soon as the payment clears and come by email.

- [Venture capital funds reported in Form ADV](https://specstream.ai/data/private-funds/venture-capital-funds): 46,659 rows, the SEC's Form ADV Part 1 data files through October 31, 2026, $546.59. Buy: https://specstream.ai/data/private-funds/venture-capital-funds
- [Private funds reported in Form ADV](https://specstream.ai/data/private-funds): 126,391 rows, the SEC's Form ADV Part 1 data files through October 31, 2026, $1,343.91. Buy: https://specstream.ai/data/private-funds

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form ADV filings every month, and this page is that reading, keyed on the SEC's private fund ID. Ask for the funds you track by type, size, adviser or service provider, and new funds and changed filings arrive in your sheet, CRM, Slack or agent as the SEC publishes them.

- Fund type: Venture capital fund
- SEC private fund ID: 805-6952478019
- Adviser: [Sofinnova Partners](https://specstream.ai/data/investment-advisers/firm/sofinnova-partners-164104)
- Adviser CRD number: 164104
- Adviser's main office: Paris, France
- Gross asset value: $7,095,033
- Beneficial owners: 19
- Minimum investment: $100,000
- Owned by non US persons: 86%
- Owned by the adviser and related persons: 2%
- Owned by funds of funds: 38%
- Fund of funds: No
- Organized in: France
- Investment Company Act exclusion: section 3(c)(1)
- Annual audit: Yes
- Form ADV filed: March 27, 2026
- Source: [The adviser's Form ADV on the SEC's adviser site](https://reports.adviserinfo.sec.gov/reports/ADV/164104/PDF/164104.pdf)

## Service providers

The firms the adviser names for this fund in Form ADV Schedule D, Section 7.B.(1).

| Firm | Role | Office |
| --- | --- | --- |
| [Forvis Mazars](https://specstream.ai/data/private-funds/auditor/forvis-mazars) | Auditor | Paris, France |
| [Societe Generale](https://specstream.ai/data/private-funds/custodian/societe-generale) | Custodian | Paris, France |
| [Societe Generale](https://specstream.ai/data/private-funds/prime-broker/societe-generale) | Prime broker | Paris, France |

## Other private funds of Sofinnova Partners

17 other funds in the same Form ADV.

| Fund | Type | Gross assets | Owners |
| --- | --- | --- | --- |
| [Sofinnova Crossover I](https://specstream.ai/data/private-funds/fund/sofinnova-crossover-i-8052688850253) | Private equity fund | $609.9 million | 59 |
| [Sofinnova Capital IX](https://specstream.ai/data/private-funds/fund/sofinnova-capital-ix-8052164711558) | Venture capital fund | $255.3 million | 46 |
| [Sofinnova Capital VIII](https://specstream.ai/data/private-funds/fund/sofinnova-capital-viii-8058871090705) | Venture capital fund | $246.3 million | 34 |
| [Sofinnova Capital X](https://specstream.ai/data/private-funds/fund/sofinnova-capital-x-8054388625969) | Venture capital fund | $207.1 million | 63 |
| [Sofinnova MD Start III](https://specstream.ai/data/private-funds/fund/sofinnova-md-start-iii-8053980480842) | Venture capital fund | $101.2 million | 28 |
| [Sofinnova Digital Medicine I](https://specstream.ai/data/private-funds/fund/sofinnova-digital-medicine-i-8052377982604) | Venture capital fund | $91.6 million | 40 |
| [Sofinnova Industrial Biotech II](https://specstream.ai/data/private-funds/fund/sofinnova-industrial-biotech-ii-8059565430427) | Venture capital fund | $90.2 million | 35 |
| [Sofinnova Industrial Biotech I](https://specstream.ai/data/private-funds/fund/sofinnova-industrial-biotech-i-8057531769244) | Venture capital fund | $73.5 million | 23 |
| [Sofinnova Telethon Sca Raif](https://specstream.ai/data/private-funds/fund/sofinnova-telethon-sca-raif-8058176056386) | Venture capital fund | $62.8 million | 27 |
| [Sofinnova Capital VII](https://specstream.ai/data/private-funds/fund/sofinnova-capital-vii-8052814985617) | Venture capital fund | $24.1 million | 35 |
| [Sofinnova Green Seed Fund](https://specstream.ai/data/private-funds/fund/sofinnova-green-seed-fund-8055720088262) | Venture capital fund | $24 million | 18 |
| [Sofinnova Capital VI](https://specstream.ai/data/private-funds/fund/sofinnova-capital-vi-8055034591677) | Venture capital fund | $22.5 million | 62 |
| [Sofinnova Coiv Eif](https://specstream.ai/data/private-funds/fund/sofinnova-coiv-eif-8056358199472) | Venture capital fund | $13.3 million | 2 |
| [Sofinnova Crossover II](https://specstream.ai/data/private-funds/fund/sofinnova-crossover-ii-8054470361477) | Private equity fund | $13.2 million | 22 |
| [Sofinnova Capital XI SCSP Sicav-Raif](https://specstream.ai/data/private-funds/fund/sofinnova-capital-xi-scsp-sicav-raif-8051219079202) | Venture capital fund | $10.3 million | 43 |
| [Sofinnova Biovelocita II](https://specstream.ai/data/private-funds/fund/sofinnova-biovelocita-ii-8056637616397) | Venture capital fund | $8.9 million | 17 |
| [Sofinnova Capital XI Co-Invest I](https://specstream.ai/data/private-funds/fund/sofinnova-capital-xi-co-invest-i-8051980600083) | Venture capital fund | $5.9 million | 4 |

## Also on SpecStream

- [Sofinnova Partners on SpecStream](https://specstream.ai/data/investment-advisers/firm/sofinnova-partners-164104)
- [Venture capital funds with under $25 million in gross assets](https://specstream.ai/data/private-funds/venture-capital-funds/size/under-25-million)
- [All venture capital funds](https://specstream.ai/data/private-funds/venture-capital-funds)
- [Private funds audited by Forvis Mazars](https://specstream.ai/data/private-funds/auditor/forvis-mazars)
- [Private funds whose custodian is Societe Generale](https://specstream.ai/data/private-funds/custodian/societe-generale)
- [Private funds whose prime broker is Societe Generale](https://specstream.ai/data/private-funds/prime-broker/societe-generale)
- [Every private fund](https://specstream.ai/data/private-funds)

Source: [the SEC's Form ADV Part 1 data files, Schedule D Section 7.B.(1)](https://adviserinfo.sec.gov/adv). Public data published by the US Securities and Exchange Commission (US government work). Advisers report these values themselves in Form ADV Schedule D, Section 7.B.(1), and neither the SEC nor the states approve or guarantee them. Gross asset value is the fund's value as the adviser reported it in its latest Form ADV filing, which can be months old. A fund that two advisers report shows under the adviser with the newer filing. Service providers are named as the adviser wrote them; a name that could be a person's is left out. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Avionics shops in the United States](https://specstream.ai/data/businesses/avionics-shops/united-states)
- [Orthodontics practices in the United States](https://specstream.ai/data/businesses/orthodontics-practices/united-states)
- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
- [Spices wholesalers in the United States](https://specstream.ai/data/businesses/spices-wholesalers/united-states)
- [Home automation companies in the United States](https://specstream.ai/data/businesses/home-automation-companies/united-states)
- [Audiology clinics in the United States](https://specstream.ai/data/businesses/audiology-clinics/united-states)
